Nahoko Tomonobu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nahoko Tomonobu has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Rie Kinoshita
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
6 shared publications - Masakiyo Sakaguchi
Department of Cell Biology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan
5 shared publications - Hitoshi Murata
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
4 shared publications - Akira Yamauchi
Department of Biochemistry, Kawasaki Medical School, Kurashiki, Japan
3 shared publications - Eisaku Kondo
Division of Tumor Pathology, Near InfraRed Photo-ImmunoTherapy Research Institute, Kansai Medical University, Hirakata, Japan
3 shared publications - I. Wayan Sumardika
Pharmacology and Therapeutic Department, Faculty of Medicine, Udayana University, Jl. P.B. Sudirman Dangin Puri Klod, West Denpasar, Bali 80234, Indonesia
3 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 330 (5) , L593-L609
The role of S100A8/A9 in the pathogenesis of acute exacerbations of pulmonary fibrosis
During acute exacerbation of idiopathic interstitial pneumonia, bronchoalveolar lavage fluid (BALF) and serum S100A8/A9 levels were elevated and associated with poor prognosis. In a mouse model of acute pulmonary fibrosis exacerbation, therapeutic targeting of S100A8/A9 attenuated lung inflammation and fibrosis, accompanied by reduced S100A8/A9 levels and neutrophil extracellular traps within airways. In vitro experiments demonstrated that neutrophil-derived S100A8/A9 promoted activation of lung fibroblasts and their differentiation into myofibroblasts, which was effectively inhibited by neutralizing antibodies.
- 1 May 2026
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 330 (5) , L593-L609
Open AccessThe role of S100A8/A9 in the pathogenesis of acute exacerbations of pulmonary fibrosis
During acute exacerbation of idiopathic interstitial pneumonia, bronchoalveolar lavage fluid (BALF) and serum S100A8/A9 levels were elevated and associated with poor prognosis. In a mouse model of acute pulmonary fibrosis exacerbation, therapeutic targeting of S100A8/A9 attenuated lung inflammation and fibrosis, accompanied by reduced S100A8/A9 levels and neutrophil extracellular traps within airways. In vitro experiments demonstrated that neutrophil-derived S100A8/A9 promoted activation of lung fibroblasts and their differentiation into myofibroblasts, which was effectively inhibited by neutralizing antibodies.
- Open Access
- 21 January 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (8) , 1930-1945.e3
An S100A8/A9 Neutralizing Antibody Potently Ameliorates Contact Hypersensitivity and Atopic Dermatitis Symptoms
- 21 January 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (8) , 1930-1945.e3
Open AccessAn S100A8/A9 Neutralizing Antibody Potently Ameliorates Contact Hypersensitivity and Atopic Dermatitis Symptoms
- Open Access
- 8 October 2024
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 2 (1)
Antithrombin regulates neutrophil activities through the stimulation of C-type lectin family 1A
- 8 October 2024
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 2 (1)
Open AccessAntithrombin regulates neutrophil activities through the stimulation of C-type lectin family 1A
- Open Access
- 26 March 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1371342
Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface
Background: Our earlier research revealed that the secreted lysyl oxidase-like 4 (LOXL4) that is highly elevated in triple-negative breast cancer (TNBC) acts as a catalyst to lock annexin A2 on the cell membrane surface, which accelerates invasive outgrowth of the cancer through the binding of integrin-β1 on the cell surface. However, whether this machinery is subject to the LOXL4-mediated intrusive regulation remains uncertain.Methods: Cell invasion was assessed using a transwell-based assay, protein–protein interactions by an immunoprecipitation–Western blotting technique and immunocytochemistry, and plasmin activity in the cell membrane by gelatin zymography.Results: We revealed that cell surface annexin A2 acts as a receptor of plasminogen via interaction with S100A10, a key cell surface annexin A2-binding factor, and S100A11. We found that the cell surface annexin A2/S100A11 complex leads to mature active plasmin from bound plasminogen, which actively stimulates gelatin digestion, followed by increased invasion.Conclusion: We have refined our understanding of the role of LOXL4 in TNBC cell invasion: namely, LOXL4 mediates the upregulation of annexin A2 at the cell surface, the upregulated annexin 2 binds S100A11 and S100A10, and the resulting annexin A2/S100A11 complex acts as a receptor of plasminogen, readily converting it into active-form plasmin and thereby enhancing invasion.
- 26 March 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1371342
Open AccessLysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface
Background: Our earlier research revealed that the secreted lysyl oxidase-like 4 (LOXL4) that is highly elevated in triple-negative breast cancer (TNBC) acts as a catalyst to lock annexin A2 on the cell membrane surface, which accelerates invasive outgrowth of the cancer through the binding of integrin-β1 on the cell surface. However, whether this machinery is subject to the LOXL4-mediated intrusive regulation remains uncertain.Methods: Cell invasion was assessed using a transwell-based assay, protein–protein interactions by an immunoprecipitation–Western blotting technique and immunocytochemistry, and plasmin activity in the cell membrane by gelatin zymography.Results: We revealed that cell surface annexin A2 acts as a receptor of plasminogen via interaction with S100A10, a key cell surface annexin A2-binding factor, and S100A11. We found that the cell surface annexin A2/S100A11 complex leads to mature active plasmin from bound plasminogen, which actively stimulates gelatin digestion, followed by increased invasion.Conclusion: We have refined our understanding of the role of LOXL4 in TNBC cell invasion: namely, LOXL4 mediates the upregulation of annexin A2 at the cell surface, the upregulated annexin 2 binds S100A11 and S100A10, and the resulting annexin A2/S100A11 complex acts as a receptor of plasminogen, readily converting it into active-form plasmin and thereby enhancing invasion.
- Open Access
- 1 June 2020
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 324, 109085
Xylitol acts as an anticancer monosaccharide to induce selective cancer death via regulation of the glutathione level
- 1 June 2020
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 324, 109085
Open AccessXylitol acts as an anticancer monosaccharide to induce selective cancer death via regulation of the glutathione level
- Open Access
- 21 June 2019
- Published by Tech Science Press in Oncology Research
- Vol. 27 (6) , 713-727
Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers
The fertile stroma in pancreatic ductal adenocarcinomas (PDACs) has been suspected to greatly contribute to PDAC progression. Since the main cell constituents of the stroma are fibroblasts, there is crosstalking(s) between PDAC cells and surrounding fibroblasts in the stroma, which induces a fibroblast proliferation burst. We have reported that several malignant cancer cells including PDAC cells secrete a pronounced level of S100A11, which in turn stimulates proliferation of cancer cells via the receptor for advanced glycation end products (RAGE) in an autocrine manner. Owing to the RAGE+ expression in fibroblasts, the extracellular abundant S100A11 will affect adjacent fibroblasts. In this study, we investigated the significance of the paracrine axis of S100A11‐RAGE in fibroblasts for their proliferation activity. In in vitro settings, extracellular S100A11 induced upregulation of fibroblast proliferation. Our mechanistic studies revealed that the induction is through RAGE‐MyD88‐mTOR‐p70 S6 kinase upon S100A11 stimulation. The paracrine effect on fibroblasts is linked mainly to triggering growth but not cellular motility. Thus, the identified pathway might become a potential therapeutic target to suppress PDAC progression through preventing PDAC-associated fibroblast proliferation.
- 21 June 2019
- Published by Tech Science Press in Oncology Research
- Vol. 27 (6) , 713-727
Open AccessExtracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers
The fertile stroma in pancreatic ductal adenocarcinomas (PDACs) has been suspected to greatly contribute to PDAC progression. Since the main cell constituents of the stroma are fibroblasts, there is crosstalking(s) between PDAC cells and surrounding fibroblasts in the stroma, which induces a fibroblast proliferation burst. We have reported that several malignant cancer cells including PDAC cells secrete a pronounced level of S100A11, which in turn stimulates proliferation of cancer cells via the receptor for advanced glycation end products (RAGE) in an autocrine manner. Owing to the RAGE+ expression in fibroblasts, the extracellular abundant S100A11 will affect adjacent fibroblasts. In this study, we investigated the significance of the paracrine axis of S100A11‐RAGE in fibroblasts for their proliferation activity. In in vitro settings, extracellular S100A11 induced upregulation of fibroblast proliferation. Our mechanistic studies revealed that the induction is through RAGE‐MyD88‐mTOR‐p70 S6 kinase upon S100A11 stimulation. The paracrine effect on fibroblasts is linked mainly to triggering growth but not cellular motility. Thus, the identified pathway might become a potential therapeutic target to suppress PDAC progression through preventing PDAC-associated fibroblast proliferation.